• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes

Recent Advances in the Study of (4-Bromonaphthalen-2-yl)acetonitrile (CAS: 401469-73-6) in Chemical Biology and Pharmaceutical Research

The compound (4-Bromonaphthalen-2-yl)acetonitrile (CAS: 401469-73-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications as a key intermediate in the synthesis of bioactive molecules. This research briefing provides an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications.

Recent studies have highlighted the role of (4-Bromonaphthalen-2-yl)acetonitrile in the development of novel kinase inhibitors, particularly in the context of cancer therapy. Researchers have successfully utilized this compound as a building block for the synthesis of small-molecule inhibitors targeting specific oncogenic kinases. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the synthesis of potent and selective inhibitors of the JAK-STAT signaling pathway, which plays a crucial role in various hematological malignancies.

In addition to its applications in oncology, (4-Bromonaphthalen-2-yl)acetonitrile has shown promise in the development of anti-inflammatory agents. A recent publication in Bioorganic & Medicinal Chemistry Letters reported its use as a precursor for the synthesis of novel COX-2 inhibitors with improved selectivity profiles. The study revealed that derivatives of this compound exhibited significant anti-inflammatory activity in vitro and in vivo, with reduced gastrointestinal side effects compared to traditional NSAIDs.

The synthetic versatility of (4-Bromonaphthalen-2-yl)acetonitrile has been further demonstrated in the field of neurodegenerative disease research. A 2024 study published in ACS Chemical Neuroscience described its application in the development of small molecules targeting α-synuclein aggregation, a key pathological feature of Parkinson's disease. The researchers successfully modified the compound to create novel inhibitors that showed promising results in both biochemical and cell-based assays.

From a chemical perspective, recent advances in the synthesis and modification of (4-Bromonaphthalen-2-yl)acetonitrile have been reported in several high-impact journals. A notable development is the application of transition metal-catalyzed cross-coupling reactions to create diverse derivatives of this compound. These synthetic methodologies have significantly expanded the structural diversity accessible from this scaffold, enabling more comprehensive structure-activity relationship studies.

Looking forward, the unique chemical properties of (4-Bromonaphthalen-2-yl)acetonitrile continue to inspire innovative research across multiple therapeutic areas. Its combination of synthetic accessibility and biological relevance makes it an attractive starting point for medicinal chemistry programs. Future research directions may include further exploration of its applications in targeted protein degradation, allosteric modulator development, and the creation of bifunctional pharmacological agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)